It is with great pleasure that we invite you to join the 2nd Annual Kidney Conference (Special CME, CPD Accreditation and Certification event) from 28th to 30th August 2017 to be held at Philadelphia, USA
The scientific committee preparing the program with great care to provide a world-class scientific program to make this event again a memorable one by complementing up to date research sessions with diverse educational symposia and a galaxy of eminent national and international speakers will participate. We have collaborations and partnerships with various organizations.
In addition to practical aspects of routine clinical nephrologist it is also very important to remain in touch with the latest advances and innovations and exchange ideas by the national and international eminent speakers and researchers.
Philadelphia is the beautiful, historical and entertainment city of USA. Moreover, the weather in August will be very pleasant. You will thus have the opportunity to enjoy many other things in around Philadelphia besides the conference.
Dear prospective delegates, we strongly encourage you to take full advantage of the opportunity to attend the 2nd Annual Kidney Conference being held in Philadelphia, USA. On behalf of the organizing committee we extend a very warm welcome & promise a comfortable stay, great scientific content & pleasant memories to take home.
Come and enjoy the biggest event of our specialty, full of scientific innovations, enriching moments with their peers and also treat this charming and hospitable city!
The Florida Urological Society is dedicated to furthering the specialty of urology, the education of future urologists, the education of the public and its members, and supporting individual practices. FUS provides access to invaluable resources to help solve your most complex challenges. Newsletters, position papers, fact sheets, web sites, news briefs, and other services created to help you stay on top of new advances in the specialty!
Urology is a constantly evolving field that requires the persistent review of diagnostic and treatment strategies. Specifically, there is new and emerging information in the areas of prostate cancer, bladder cancer, penile cancer, and men’s health. Urologic providers need up-to-date reviews of these topics that affect the care of their patients.
At the conclusion of the GUA 2017 Annual meeting, attendees will be able to:
- Identify how MRI can be used for prostate cancer evaluation and can influence treatment options.
- Explain how MRI can be used for renal cancer and lesion evaluation and can influence treatment options.
- Describe the utilization of robotic surgery in novel approaches in urology for benign and reconstructive urologic conditions.
- Describe state of the art modifications in technique for robotic surgery in the treatment of prostate cancer.
- Describe the technique of Retzius Sparing Robotic Radical Prostatectomy and report Early Outcomes of this technique in the USA.
- Explain the role of robotic surgery for urolithiasis.
- Acquire a better understanding of dermatologic conditions that urologists may see and treat.
- Review the current best practices in treatment of Peyronie’s disease and urethral reconstruction.
- Explain treatment options for priapism.
- Utilize and better understand the current CPT, E&M and ICD-10 coding practices.
- Report a comparative outcome of Robotic radical cystectomy versus open cystectomy.
- Describe the technique of minimizing peritoneal seeding during robotic radical cystectomy.
- Explain MACRA and how it will impact urology practice.
- Identify basic scientific and clinical research that may advance urological clinical performance.
- Discuss the diagnosis and management options for urologic disorders and recent changes in guidelines for screening and treatment of these disorders.
- Recognize and manage complications of laparoscopic and robotic surgery.
- Evaluate new techniques for improving patient safety with regards to urologic patients.
- Apply advances in reconstructive urology, urologic oncology and pediatric oncology.
- Detail new surgical procedures as well as their respective risks and benefits.
- Discuss the latest socioeconomic issues affecting ones daily urologic practice.
The Department of Urology at the Mount Sinai Health System is hosting its 2nd Annual International Prostate Cancer Symposium and Inaugural World Congress in collaboration with Society of Urologic Robotic Surgeons and Endourological Society. More than 110 renowned faculty from around the world will participate in Live 3D surgical demonstrations, including prostate, kidney and bladder and reconstruction as well as Inaugural Symposiums: Immunotherapy of Prostate Cancer and GU Cancers and World Consortium on Advanced Prostate Cancer.
Lecture topics will include immunotherapy and tumor microenvironment, active surveillance, focal therapy, advanced prostate cancer, locally advanced disease, radical prostatectomy, morbidity and quality of life. Participants will also discuss the recent U.S. Services Preventative Task Force (USPSTF) recommendations that encourage men ages 55 to 69 to “make an individualized decision about prostate screening with their clinician.”
Integrating science into oncology for a better patient outcome. In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge.
The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients.